+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
3SBio Inc - logo

3sbio is a biotechnology company that creates biopharmaceutical products. The company was incorporated in 2006, and is headquartered in Shenyang, China. It is a subsidiary of Decade Sunshine Limited. Their products include TPIAO, a recombinant human thrombopoietin for thrombocytopenia; and EPIAO, an injectable recombinant human erythropoietin for anemia associated with chronic kidney disease (CKD) and chemotherapy, as well as to reduce allogeneic blood transfusion in surgery patients. 3sbio sell their products to a range of countries including: Brazil, Colombia, Costa Rica ,Dominican Republic, Egypt, El Salvador, Guatemala, Laos, Mongolia, Myanmar, Pakistan, Paraguay, Philippines, Sri Lanka, Thailand and Trinidad and Tobago.

Avastin (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships - Product Thumbnail Image

Avastin (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive/Terminated/Withdrawn Biosimilars, Industry/Non-Industry Partnerships

  • Report
  • August 2021
  • 91 Pages
  • Global
From
Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030 - Product Thumbnail Image

Live Biotherapeutic Products and Microbiome Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients and Finished Dosage Forms, 2020-2030

  • Report
  • March 2020
  • 306 Pages
  • Global
From
Biosimilar Monoclonal Antibodies Market Report 2022-2032 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Market Report 2022-2032

  • Report
  • July 2022
  • 461 Pages
  • Global
From
Global Biosimilar Monoclonal Antibodies Market by Drug Class (Abciximab, Adalimumab, Bevacizumab), Application (Diagnostic, Protein Purification, Therapeutic) - Forecast 2024-2030 - Product Thumbnail Image

Global Biosimilar Monoclonal Antibodies Market by Drug Class (Abciximab, Adalimumab, Bevacizumab), Application (Diagnostic, Protein Purification, Therapeutic) - Forecast 2024-2030

  • Report
  • March 2024
  • 185 Pages
  • Global
From
Biosimilars and Follow-On Biologics Market Report 2023-2033 - Product Thumbnail Image

Biosimilars and Follow-On Biologics Market Report 2023-2033

  • Report
  • December 2022
  • 337 Pages
  • Global
From
Biosimilar Monoclonal Antibodies Global Market Report 2024 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions - Product Thumbnail Image

Global Biologics Contract Manufacturing (Biopharma CDMO/Biopharma CMO/Biologics Manufacturing) Market 2022-2035 by Type of Service(s) Offered, Type of Biologic Manufactured, Type of Expression System Used, Scale of Operation, Company Size, and Key Geographical Regions

  • Report
  • December 2023
  • 799 Pages
  • Global
From
Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gouty Arthritis (Gout) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 133 Pages
  • Global
From
ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

ADC Technology Market: Focus on ADC Linker and ADC Conjugation Technologies (2nd Edition) - Distribution by Generation of ADC Technology, Type of Conjugation, Type of Linker and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • July 2023
  • 407 Pages
  • Global
From
Anemia in Chronic Kidney Disease (Renal Anemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Anemia in Chronic Kidney Disease (Renal Anemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 99 Pages
  • Global
From
Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022 - Product Thumbnail Image

Biopharmaceutical Contract Manufacturing Organization (BCMO) Market, 2022

  • Report
  • August 2022
  • 180 Pages
  • Global
From
Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 82 Pages
  • Global
From
Oral Biologics & Biosimilar Drugs Global Market Report 2024 - Product Thumbnail Image

Oral Biologics & Biosimilar Drugs Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Type 2 Diabetes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • October 2022
  • 1127 Pages
  • Global
From
China Bispecific Antibodies Market and Clinical Pipeline Insight 2028 - Product Thumbnail Image

China Bispecific Antibodies Market and Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 400 Pages
  • China
From
Oral Biologics & Biosimilars Global Market Report 2024 - Product Thumbnail Image

Oral Biologics & Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities - Product Thumbnail Image

Growth of Biopharmaceutical Contract Manufacturing Organizations in China: An In-depth Study of Emerging Opportunities

  • Report
  • June 2020
  • 100 Pages
  • China
From
Global Chemotherapy Induced Anemia Market by Range Of Anemia (Life-Threatening Anemia, Mild Anemia, Moderate Anemia), Treatment (Erythropoiesis-Stimulating Agents, Iron Supplementation, RBC Transfusions), Drug, End-User - Forecast 2024-2030 - Product Thumbnail Image

Global Chemotherapy Induced Anemia Market by Range Of Anemia (Life-Threatening Anemia, Mild Anemia, Moderate Anemia), Treatment (Erythropoiesis-Stimulating Agents, Iron Supplementation, RBC Transfusions), Drug, End-User - Forecast 2024-2030

  • Report
  • March 2024
  • 188 Pages
  • Global
From
Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030 - Product Thumbnail Image

Generics Market: Focus on Value-Added Medicines / Supergenerics, 2019-2030

  • Report
  • October 2019
  • 231 Pages
  • Global
From
Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Therapeutic Areas and Key Geographies: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • October 2023
  • 552 Pages
  • Global
From
Loading Indicator